Upgrade to SI Premium - Free Trial

Adaptive Biotechnologies (ADPT)

24.28 -0.29 (1.18%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference September 1, 2026 4:05 PM - StreetInsider Form 4 Adaptive Biotechnologies For: Aug 26 Filed by: OWEN KATEY EINTERZ August 28, 2026 5:50 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: OWEN KATEY EINTERZ August 26, 2026 4:14 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 20, 2026 6:07 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 18 Filed by: HERSHBERG ROBERT August 20, 2026 5:56 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 17 Filed by: ROBINS CHAD M August 19, 2026 8:15 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 17 Filed by: NEUPERT PETER M August 19, 2026 8:08 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 19, 2026 6:28 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: HERSHBERG ROBERT August 18, 2026 6:18 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS CHAD M August 18, 2026 5:45 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 18, 2026 5:45 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S August 17, 2026 5:21 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS CHAD M August 17, 2026 5:21 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: NEUPERT PETER M August 17, 2026 4:49 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Aug 10 Filed by: BOBULSKY SUSAN August 12, 2026 7:34 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN August 10, 2026 4:38 PM - SEC Filing Form 10-Q Adaptive Biotechnologies For: Jun 30 August 4, 2026 4:32 PM - SEC Filing Adeptus Biotechnologies Corp. (ADPT) PT Raised to $27.50 at Piper Sandler August 4, 2026 6:54 AM - StreetInsider Form 4 Adaptive Biotechnologies For: Jul 30 Filed by: BOBULSKY SUSAN August 3, 2026 6:27 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN July 30, 2026 4:38 PM - SEC Filing Adeptus Biotechnologies Corp. (ADPT) PT Raised to $28 at TD Cowen July 30, 2026 9:09 AM - StreetInsider Adaptive Biotechnologies Corp. (ADPT) PT Raised to $27 at JPMorgan July 30, 2026 8:57 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $22 at Morgan Stanley July 30, 2026 8:13 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $25 at Guggenheim July 30, 2026 6:41 AM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $25 at BTIG July 30, 2026 5:10 AM - StreetInsider Adaptive Biotechnologies (ADPT) Misses Q2 EPS by 11c July 29, 2026 4:46 PM - StreetInsider Form 8-K Adaptive Biotechnologies For: Jul 24 July 29, 2026 4:15 PM - SEC Filing Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results July 29, 2026 4:05 PM - StreetInsider Form 4 Adaptive Biotechnologies For: Jul 21 Filed by: ROBINS HARLAN S July 23, 2026 7:35 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S July 21, 2026 5:21 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jul 16 Filed by: BOBULSKY SUSAN July 20, 2026 7:20 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jul 15 Filed by: LO FRANCIS July 17, 2026 7:24 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN July 16, 2026 4:35 PM - SEC Filing Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026 July 9, 2026 4:05 PM - StreetInsider Adeptus Biotechnologies Corp. (ADPT) PT Raised to $20 at Morgan Stanley July 9, 2026 8:15 AM - StreetInsider Form 4 Adaptive Biotechnologies For: Jul 02 Filed by: ROBINS HARLAN S July 7, 2026 6:53 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jul 01 Filed by: LO FRANCIS July 6, 2026 7:19 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jul 01 Filed by: BOBULSKY SUSAN July 6, 2026 7:16 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S July 2, 2026 5:43 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: LO FRANCIS July 1, 2026 4:36 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN July 1, 2026 4:17 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jun 26 Filed by: BENZENO SHARON June 30, 2026 7:25 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jun 25 Filed by: BOBULSKY SUSAN June 29, 2026 7:53 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jun 25 Filed by: GRIFFIN MICHELLE RENEE June 29, 2026 7:50 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BENZENO SHARON June 29, 2026 4:49 PM - SEC Filing Adeptus Biotechnologies Corp. (ADPT) PT Raised to $22 at Guggenheim June 29, 2026 6:54 AM - StreetInsider Form 144 Adaptive Biotechnologies Filed by: BENZENO SHARON June 26, 2026 4:42 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN June 25, 2026 4:26 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: GRIFFIN MICHELLE RENEE June 25, 2026 4:26 PM - SEC Filing Adaptive Biotechnologies issues $345M in convertible notes due 2031 June 22, 2026 4:10 PM - StreetInsider Form 8-K Adaptive Biotechnologies For: Jun 15 June 22, 2026 4:07 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jun 15 Filed by: ROBINS HARLAN S June 17, 2026 8:11 PM - SEC Filing BTIG Reiterates Buy Rating on Adeptus Biotechnologies Corp. (ADPT) June 17, 2026 11:00 AM - StreetInsider Adaptive Biotechnologies prices $300M convertible notes due 2031 June 17, 2026 6:00 AM - StreetInsider Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering June 17, 2026 6:00 AM - StreetInsider Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S June 16, 2026 6:05 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jun 11 Filed by: BOBULSKY SUSAN June 15, 2026 7:13 PM - SEC Filing Form 144 Adaptive Biotechnologies Filed by: ROBINS HARLAN S June 15, 2026 6:10 PM - SEC Filing Form 8-K Adaptive Biotechnologies For: Jun 15 June 15, 2026 4:16 PM - SEC Filing Adaptive Biotechnologies (ADPT) to Separate Its MRD and Immune Medicine Businesses June 15, 2026 4:10 PM - StreetInsider Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses June 15, 2026 4:10 PM - StreetInsider Adaptive Biotechnologies (ADPT) to offer $250 million in convertible senior notes due 2031 June 15, 2026 4:07 PM - StreetInsider Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering June 15, 2026 4:05 PM - Globe NewsWire Form 144 Adaptive Biotechnologies Filed by: BOBULSKY SUSAN June 11, 2026 4:38 PM - SEC Filing Form 8-K Adaptive Biotechnologies For: Jun 05 June 9, 2026 4:31 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jun 04 Filed by: LO FRANCIS June 8, 2026 8:29 PM - SEC Filing Form 4 Adaptive Biotechnologies For: Jun 04 Filed by: BOBULSKY SUSAN June 8, 2026 8:27 PM - SEC Filing Full Article List